<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04355923</url>
  </required_header>
  <id_info>
    <org_study_id>20rhumatocovid01</org_study_id>
    <nct_id>NCT04355923</nct_id>
  </id_info>
  <brief_title>Confinement and Spondyloarthritis Treatment</brief_title>
  <official_title>Impact of Confinement on the Treatment of Spondyloarthritis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the impact of confinement on treatment use in spondyloarthritis. Study hypothesis
      that with the confinement, subjects will stop their treatment. The main objective is to study
      the impact of confinement on treatment. And secondly to look for for specific psychological
      profile linked to the interruption of the treatment. the study population consists of
      patients with spondyloarthritis and belonging to a patient association (ACS). All patients
      over 18 are included. A mailing questionnaire will be send to all patients. data on diseases
      activity and treatment will be collected
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2020</start_date>
  <completion_date type="Anticipated">May 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>treatment use</measure>
    <time_frame>1 month</time_frame>
    <description>treatment continuation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>activity of disease</measure>
    <time_frame>1 week</time_frame>
    <description>number of crisis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>psychological aspects</measure>
    <time_frame>1 month</time_frame>
    <description>Ten Item Personality Inventory rated on a scale from 1, disagree strongly, to 7, agree strongly)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>psychological aspects</measure>
    <time_frame>1 month</time_frame>
    <description>quality of life questionnaire (EQ-5D) evaluating mobility, self care, usual activity, pain and anxiety</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Spondyloarthritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with spondyloarthritis and member of ACS patient association group
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  spondyloarthritis,

          -  age over 18 ans

          -  treatment by NSAID or biological treatment to be part of the patient association &quot;ACS&quot;
             (action contre les spondylarthropathies).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Christian Roux, MD, PhD</last_name>
    <phone>+334 92 03 54 91</phone>
    <email>roux.c2@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olivier BROCQ</last_name>
    <email>olivier.brocq@chpg.mc</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Roux</last_name>
      <email>roux.c2@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 16, 2020</study_first_submitted>
  <study_first_submitted_qc>April 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2020</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no data sharing plan has been established</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

